Psychiatric Polypharmacy Continues To Grow

The following links to an article about a study of prescribing practices by psychiatrists.  It shows that Polypharmacy (using combinations of medications) is growing significantly for treatment of depression.  The article also expresses concern that there is no evidence base to support this.

MedPage Today

Submitted by: Darrell H.

FDA Approves New Long Acting Injectible Antipsychotic

The FDA has approved a new long acting injection of the antipsychotic Zyprexa.  The following article tells about the treatment protocol that must be used when using this product.  Many critics feel that this protocol is such that this treatment is practically unusable.

Medical News

Submitted by: Darrell H.